Client business need
HEOR, medical, and market access teams at a global pharmaceutical company are responsible for different aspects of evidence management. Evidence underpinned everything from global value dossiers and SLRs to HTA submissions and lifecycle strategy. Senior evidence leaders were accountable for evidence quality, consistency, and delivery against tight submission timelines.
However, evidence was fragmented across teams and vendors. Publications, internal analyses, and data on file were stored in multiple systems, leading to duplication of effort, version confusion, and uncertainty over which evidence was approved for use. Maintaining an up-to-date evidence base required significant manual effort, with dedicated analysts focused on tracking and summarising new publications.
As submission deadlines approached, gaps in evidence or inconsistencies across materials were often discovered late in the process, creating rework and risk at the point when HTA readiness mattered most.
Client goals
The organisation wanted to strengthen governance and control over evidence generation and use. Key objectives included:
- Creating a single, trusted source of truth for all evidence assets
- Ensuring evidence was consistent, curated, and submission-ready for HTA requirements across markets
- Reducing duplication of work across HEOR, medical, market access teams, and vendors
- Improving early visibility of evidence gaps and competitive risks
- Freeing up senior evidence teams to focus on strategy rather than manual maintenance
Ultimately, the goal was to deliver high-quality, HTA-ready evidence packages with greater confidence and predictability.
Access Infinity response
Access Infinity implemented Evidence Hub as a centralised, AI-enabled platform for evidence generation, curation, and governance.
Evidence Hub consolidated published literature, internal data on file, clinical study reports, and competitor evidence into a single, living library. Automated monitoring continuously scanned predefined databases, with quality controls ensuring accuracy and completeness. Custom taxonomies and metadata enabled teams to manage evidence according to defined standards.
AI-powered capabilities were layered on top of the curated library, allowing users to extract insights quickly without manually reviewing hundreds of publications. Built-in guardrails ensured outputs were grounded only in approved evidence. Curation workflows, metadata control, and quality checks ensured teams worked from submission-ready content rather than ad hoc document versions.
By serving as a shared environment for HEOR, medical, market access, and external vendors, Evidence Hub reduced handoffs and enabled faster, more coordinated evidence development.
Business impact
- Greater confidence in HTA submissions through consistent, governed evidence assets
- Earlier identification of evidence gaps and competitive risks, reducing last-minute rework
- Improved coordination across HEOR teams, medical, market access, and external vendors
- Reduced administrative burden by automating evidence tracking and updates
- Faster onboarding and knowledge transfer for new team members
Evidence Hub transformed evidence generation from a fragmented, high-risk process into a controlled, scalable capability that supported HTA success.
Find out more
To learn how Evidence Hub helps HEOR and evidence teams deliver consistent, HTA-ready evidence at scale, visit the Evidence Hub landing page on our website.
If you would like to see it in action, book a personalised demo to explore how Evidence Hub can support evidence generation, governance, and submission readiness across your organisation.
